TDO2 and cancer: As a result, the overexpression of the tryptophan‐degrading enzymes such as indoleamine 2,3‐dioxygenase (IDO) and tryptophan 2,3‐dioxygenase (TDO) in cancer has led to extended research on the tryptophan–kynurenine pathway in cancer.7, 9